Optimal Screening of Populations with Heterogeneous Risk Profiles Under the Availability of Multiple Tests
Published Online:21 May 2021https://doi.org/10.1287/ijoc.2020.1051
References
- American Red Cross. Infectious Disease, HLA and ABO Donor Qualification Testing. Accessed January 21, 2021, https://www.redcrossblood.org/biomedical-services/blood-diagnostic-testing/blood-testing.html.Google Scholar
- (2019) Optimal risk-based group testing. Management Sci. 65(9):4365–4384.Google Scholar
- (1990) Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models. AIDS 4(8):737–741.Crossref, Google Scholar
- (1958) On a routing problem. Quart. Appl. Math. 16(1):87–90.Crossref, Google Scholar
- (1984) Random multiple-access communication and group testing. IEEE Trans. Comm. 32(7):769–779.Crossref, Google Scholar
- (2014) A probabilistic method for the estimation of residual risk in donated blood. Biostatistics 15(4):620–635.Crossref, Google Scholar
- (2012) Group testing in heterogeneous populations by using halving algorithms. J. Roy. Statist. Soc. Ser. C. Appl. Statist. 61(2):277–290.Crossref, Google Scholar
- Centers for Disease Control and Prevention. HIV, Hepatitis, STD, TB, Social Determinants of Health Data. Accessed March 1, 2019, https://www.cdc.gov/nchhstp/atlas/index.htm.Google Scholar
- (1982) Technical note: A partitioning problem with additive objective with an application to optimal inventory groupings for joint replenishment. Oper. Res. 30(5):1018–1022.Link, Google Scholar
- (1943) The detection of defective members of large populations. Ann. Math. Statist. 14(4):436–440.Crossref, Google Scholar
- (2017) Optimal pooling strategies for nucleic acid testing of donated blood considering viral load growth curves and donor characteristics. IISE Trans. Healthcare Systems Engrg. 7(1):15–29.Crossref, Google Scholar
- (2009) Resource constrained shortest paths and extensions. Unpublished doctoral thesis, School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta.Google Scholar
- (1972) Group testing in the presence of test error; an extension of the Dorfman procedure. Technometrics 14(1):113–122.Crossref, Google Scholar
- HOLOGIC. Panther Scalable Solutions. Accessed January 21, 2021, https://www.hologic.com/hologic-products/diagnostic-solutions/Panther-Scalable-Solutions.Google Scholar
- (2011) Optimal configuration of a square array group testing algorithm. Comm. Statist. Theory Methods 40(3):436–448.Crossref, Google Scholar
- (1975) A generalized binomial group testing problem. J. Amer. Statist. Assoc. 70(352):923–926.Crossref, Google Scholar
- (1991) Inspection Errors for Attributes in Quality Control, vol. 44 (CRC Press, Boca Raton, FL).Crossref, Google Scholar
- (2004) Multistage group testing procedure (group screening). Comm. Statist. Simulation Comput. 33(3):621–637.Crossref, Google Scholar
- (2007) Comparison of group testing algorithms for case identification in the presence of test error. Biometrics 63(4):1152–1163.Crossref, Google Scholar
- (2011) HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: A cost-effectiveness analysis. PLoS One 6(11):e27625.Crossref, Google Scholar
- (2012) Informative Dorfman screening. Biometrics 68(1):287–296.Crossref, Google Scholar
- (1994) The use of a square array scheme in blood testing. Statist. Medicine 13(22):2337–2343.Crossref, Google Scholar
- Google Scholar
- (2013) Comparative analysis of triplex nucleic acid test assays in United States blood donors. Transfusion 53(10):2525–2537.Crossref, Google Scholar
- (1975) On some numbers related to the Bell numbers. Canadian Math. Bull. 17(5):733–738.Crossref, Google Scholar
- U.S. Department of Health and Human Services. Summary of Notifiable Diseases, United States, 2012. Accessed March 1, 2019, https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6153a1.htm.Google Scholar
- (1996) Pooled testing for HIV screening: Capturing the dilution effect. Oper. Res. 44(4):543–569.Link, Google Scholar
- (2012) Donor testing and risk: Current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations. Transfusion Medicine Rev. 26(2):119–128.Crossref, Google Scholar

